Clear cell adenocarcinoma of the female urethra is extremely rare. Because the primary urethral carcinomas are rare, standard diagnostic algorism and management has not been established yet. We report a case of clear cell adenocarcinoma of the proximal urethra in a 76-year-old female. She was presented with voiding difficulty for several years after pubovaginal sling operation due to stress urinary incontinence twelve years ago. Before this period, she had managed with medication for detrusor hypocontractility. Recently she complained bloody vaginal discharge, and her vaginal examination revealed palpable mass on the anterior vaginal wall. Pelvic MRI showed a 5x4.5cm sized tumor surrounding the proximal urethra which was mimicking prostate with no lymphadenopathy. Biopsy of the mass confirmed it to be clear cell adenocarcinoma. She underwent anterior pelvic exenteration and ileal conduit with bilateral pelvic lymph node dissection. The patient received adjuvant radiotherapy and chemotherapy as treatment. We should carefully evaluate patients with voiding symptom after anti-incontinence surgery and multimodal treatment should be applied for locally advanced urethral carcinoma. procedure. 4 We report a case of a clear cell adenocarcinoma of female urethra in patient with obstructive voiding symptom after pubovaginal sling operation for stress urinary incontinence.
Among them, the clear cell carcinomas of female urethra are extremely rare, accounting for only 10% of urethral cancer. 2 Primary urethral carcinomas may present with obstructive symptoms, dysuria, urethral bleeding, urinary frequency and palpable mass. 3 Obstructive voiding symptoms are not uncommon complications after the pubovaginal sling and midurethral sling (MUS) procedure. 4 We report a case of a clear cell adenocarcinoma of female urethra in patient with obstructive voiding symptom after pubovaginal sling operation for stress urinary incontinence.
CASE REPORT
A 76-year-old female patient was presented with voiding difficulty for a long time after pubovaginal sling operation due to stress urinary incontinence twelve years ago. Before this period, she had managed with medication for detrusor hypocontractility. Recently her voiding symptoms had worsened with complained bloody vaginal discharge, and her vaginal examination revealed non-tender, fixed hard, egg sized palpable mass on the anterior vaginal wall. No palpable inguinal lymphadenopathy was identified while the urinalysis showed hemato-pyuria. Pelvic MRI with contrast revealed a 5x4.5cm sized tumor surrounding the proximal urethra with no lymphadenopathy ( Fig. 1 ). On cystourethroscopy, the urethra and bladder seemed normal. Abdominal CT scan with contrast and chest X-ray was nonspecific findings. Needle biopsy of the mass revealed a clear cell adenocarcinoma of the urethra. The patient Voiding dysfunction after incontinence surgery is a potential complication of all stress incontinence procedures. 10 Obstructive voiding dysfunction is recognized as the most common reported complication of TA sling placement, affecting 17-50% of patients. 11 In this report, because she only complained about the obstructive voiding symptom after pubovaginal sling operation, we diagnosed the urethral cancer later in time.
Treatments of localized urethral carcinoma in female include urethrectomy, urethra-sparing surgery and radiotherapy. 
